MedTech World - North America Conference Day 1

Why It Matters

By fostering cross‑border collaborations and aligning investors with clinicians, MedTech World accelerates the delivery of life‑saving technologies to patients and drives economic growth in the health‑tech sector.

Key Takeaways

• MedTech World links clinicians, investors, and innovators to accelerate healthcare solutions.
• Malta’s ambassador highlights diplomatic role in promoting Maltese med‑tech abroad.
• Panel discusses strategies for selling and scaling health tech in 2026.
• Dermacensor showcases rapid, low‑cost skin cancer diagnostic handheld device.
• Collaboration, regulatory alignment, and funding are critical for market entry.

Summary

The opening day of MedTech World North America 2026 set the stage for a two‑day gathering of healthcare innovators, investors, clinicians, and policy makers in West Palm Beach. Host Miguel introduced the conference’s mission to bridge gaps between lab‑born technologies and bedside adoption, emphasizing that meaningful connections are the engine of progress. Key insights emerged from the keynote by co‑founder Dr. Dylan Atard, who described the persistent friction between clinicians and technology developers, and from Malta’s ambassador, who framed the event as a diplomatic showcase for Maltese med‑tech excellence, highlighting partnership building and regulatory harmonisation. The first panel, featuring leaders from Dermacensor, the Florida Hospital Association, University of Miami Health System, and Gunster law firm, dissected practical pathways for breaking into complex health‑system markets and scaling solutions by 2026. Notable moments included Atard’s remark that “the right founder never met the right investor” and the ambassador’s call for joint research, clinical trials, and knowledge exchange across the Atlantic. Dermacensor’s CEO Cody Simmons demonstrated a handheld skin‑cancer detector that delivers results in under 30 seconds, exemplifying the rapid, low‑cost innovations the conference aims to spotlight. The implications are clear: successful commercialization now hinges on coordinated networking, streamlined regulatory processes, and targeted capital. Attendees left with actionable contacts and a roadmap for navigating the evolving U.S. health‑care landscape, underscoring the conference’s role as a catalyst for next‑generation medical technology deployment.